0001104659-23-081674.txt : 20230717
0001104659-23-081674.hdr.sgml : 20230717
20230717170307
ACCESSION NUMBER: 0001104659-23-081674
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230713
FILED AS OF DATE: 20230717
DATE AS OF CHANGE: 20230717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Jennifer A.
CENTRAL INDEX KEY: 0001841557
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41740
FILM NUMBER: 231092249
MAIL ADDRESS:
STREET 1: C/O NUVATION BIO INC.
STREET 2: 1500 BROADWAY, SUITE 1401
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apogee Therapeutics, Inc.
CENTRAL INDEX KEY: 0001974640
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 880588063
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT ST.
STREET 2: BUILDING 17, SUITE 102B
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 650-394-5230
MAIL ADDRESS:
STREET 1: 221 CRESCENT ST.
STREET 2: BUILDING 17, SUITE 102B
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: Apogee Therapeutics, LLC
DATE OF NAME CHANGE: 20230420
3/A
1
tm2321456-5_3aseq1.xml
OWNERSHIP DOCUMENT
X0206
3/A
2023-07-13
2023-07-13
0
0001974640
Apogee Therapeutics, Inc.
APGE
0001841557
Fox Jennifer A.
C/O APOGEE THERAPEUTICS, INC.
221 CRESCENT ST., BLDG. 17, STE. 102B.
WALTHAM
MA
02453
1
0
0
0
Common Stock
34824
D
Consists of 34,824 shares of restricted common stock, one quarter of which will vest on May 26, 2024, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.
This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.
/s/ Jane Pritchett Henderson, as attorney-in-fact for Jennifer Fox
2023-07-17